MBMihai-Ştefan Bârhală

Mihai-Ştefan Bârhală

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mihai-Ştefan Bârhală has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimizing SRS for Brain Metastases: Understanding the Volume–Gradient Index Relationship

    by Tia Popescu-Bârhală, Ionuţ Dumitru, Mihai-Ştefan Bârhală, Horia-Dan Lişcu

    Background/Objectives: The goal is to provide a straightforward framework for generating SRS-SRT plans that reliably meet high-quality dosimetric standards. That posed some questions such as which plan quality metrics should be utilized to evaluate a plan, what influences plan quality metrics the most, and finally, how to best optimize plan geometry. Our work has primarily concentrated on the second question, guided by our clinical experience. Methods: A dataset for statistical analysis was compiled by retrospectively reviewing 200 individual SRS-SRT target volumes from two centers. From the gathered data, several Linear Regression models were generated to assess the variability of plan quality metrics using statistical analysis. The most important regressor in the models were revealed to be target volume (TV), followed by a flag type variable that indicates whether the plan used to treat the referenced target contained multiple targets (MT) or not. Results: Every doubling of TV lowers Gradient Index (GI) sharply (−0.55 to −0.17) while Gradient Measure (GM) increases moderately (+0.024 cm to +0.07 cm). The model explains 85% of the variation in GI (R2 = 0.85) and 84% of GM. Conclusions: In small lesions, GI seems to be a more sensitive evaluation metric for sub-CC SRS targets, compared to GM. Dose per fraction appeared to have had no significant effect. Treating multiple targets in the same plan appears to add an average of +0.19 to GI, independent of volume, while for GM by +0.027 cm.

  • Open Access

    Rectal Angiosarcoma: A Case Report Highlighting Multidisciplinary Strategies for Rare Malignancies

    by Dan Corneliu Jinga, Sabina Sucuri, Irina M. Cazacu-Croitoru, Barhala Mihai, Bogdan Chivu

    Background and Clinical Significance: Rectal angiosarcoma is an exceptionally rare and aggressive malignancy, comprising less than 1% of soft tissue sarcomas. This case highlights the diagnostic and therapeutic challenges posed by this disease, and the lack of established guidelines emphasizing the importance of a multidisciplinary approach. Case Presentation: A 41-year-old male firefighter, with a history of heavy smoking, presented with lower abdominal pain, rectal bleeding, and urgency. Imaging and biopsy confirmed rectal angiosarcoma, stage IIIB. The patient underwent IMRT/VMAT radiation therapy followed by laparoscopic rectal amputation with colostomy. No sign of recurrence or metastatic disease was present on follow-up imaging. Conclusions: This case underlines the importance of a personalized treatment strategy and multidisciplinary collaboration in rare malignancies. Early diagnosis and cooperation across specialties are critical for achieving the best possible outcomes.